Cerenome, Inc.(CNSY)

Medical - Pharmaceuticals · Houston, TX

$1.64+0.08 (+5.13%)

Delayed quote: Oct 6, 2026, 9:34 AM EDT

EBITDA Yield: N/A

Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The EBITDA yield is N/A as of 2026-10-06T13:36:07.057Z.

Stored calculation inputs

Calculation as of: 2026-10-06T13:36:07.057Z.

Quote observation: 2026-10-06T13:34:22.000Z. Amounts in USD. The price header may show a later quote.

TTM operating EBITDA · period ending 2026-06-30: -25,997,000
Quote market capitalization: 11,288,300
Total debt · period ending 2026-06-30: 44,000
Cash · period ending 2026-06-30: 2,366,000

FMP input reference: 7e5dd7cae71be814523bfc9444594aa14e5919ebae0d9bfc7936539f469f7652

EV/EBITDA|Earnings Yield|OCF Yield|FCF Yield|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

CNSY EBITDA Yield Metrics

EBITDA YIELD

N/A

CNSY Competitors' EBITDA Yield

CNSY

Cerenome, Inc.

Current

Market Cap

$11.29M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LFWD

Lifeward Ltd.

vs CNSY

Market Cap

$10.73M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BFRG

Bullfrog AI Holdings, Inc. Common Stock

vs CNSY

Market Cap

$10.68M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BIVI

BioVie Inc.

vs CNSY

Market Cap

$11.09M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

KPRX

Kiora Pharmaceuticals, Inc.

vs CNSY

Market Cap

$11.21M

EBITDA Yield

N/A

TTM Avg

41.52%

3Y Avg

41.52%

5Y Avg

41.52%

GDTC

CytoMed Therapeutics Limited

vs CNSY

Market Cap

$11.24M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BFRI

Biofrontera Inc.

vs CNSY

Market Cap

$11.27M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CABR

Caring Brands, Inc.

vs CNSY

Market Cap

$10.09M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ADIL

Adial Pharmaceuticals, Inc.

vs CNSY

Market Cap

$11.50M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

AIMD

Ainos, Inc.

vs CNSY

Market Cap

$9.94M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EBITDA YIELD	TTM	3Y	5Y
Cerenome, Inc. (CNSY)	$11.29M	N/A	N/A	N/A	N/A
Lifeward Ltd. (LFWD)vs ›	$10.73M	N/A	N/A	N/A	N/A
Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs ›	$10.68M	N/A	N/A	N/A	N/A
BioVie Inc. (BIVI)vs ›	$11.09M	N/A	N/A	N/A	N/A
Kiora Pharmaceuticals, Inc. (KPRX)vs ›	$11.21M	N/A	41.52%	41.52%	41.52%
CytoMed Therapeutics Limited (GDTC)vs ›	$11.24M	N/A	N/A	N/A	N/A
Biofrontera Inc. (BFRI)vs ›	$11.27M	N/A	N/A	N/A	N/A
Caring Brands, Inc. (CABR)vs ›	$10.09M	N/A	N/A	N/A	N/A
Adial Pharmaceuticals, Inc. (ADIL)vs ›	$11.50M	N/A	N/A	N/A	N/A
Ainos, Inc. (AIMD)vs ›	$9.94M	N/A	N/A	N/A	N/A

EBITDA Yield Formula & Definition

EBITDA Yield = TTM EBITDA / Enterprise Value

EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EBITDA Yield: N/A

CNSY EBITDA Yield Metrics

CNSY Competitors' EBITDA Yield

EBITDA Yield Formula & Definition

Related Metrics